U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies

Evotec

Market Cap: US$1.1b

Operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.

Ono Pharmaceutical

Market Cap: US$804.1b

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Bayer

Market Cap: US$20.7b

Operates as a life science company worldwide.

Exelixis

Market Cap: US$10.1b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Biogen

Market Cap: US$16.9b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Tilray Brands

Market Cap: US$474.3m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

Halozyme Therapeutics

Market Cap: US$7.3b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

ACADIA Pharmaceuticals

Market Cap: US$2.4b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Gerresheimer

Market Cap: US$1.8b

Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Thermo Fisher Scientific

Market Cap: US$164.9b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Sandoz Group

Market Cap: US$14.0b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

Bausch Health Companies

Market Cap: US$1.7b

Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.

Gossamer Bio

Market Cap: US$188.6m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.

Bayer

Market Cap: US$20.7b

Operates as a life science company worldwide.

Arcutis Biotherapeutics

Market Cap: US$1.5b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

Kiora Pharmaceuticals

Market Cap: US$8.3m

A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases in the United States.

Heron Therapeutics

Market Cap: US$280.3m

A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.

Ayr Wellness

Market Cap: US$24.5m

Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods.

Delivra Health Brands

Market Cap: US$5.3m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.

CytomX Therapeutics

Market Cap: US$50.4m

Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

Otsuka Holdings

Market Cap: US$3.6t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Mettler-Toledo International

Market Cap: US$21.2b

Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

Puma Biotechnology

Market Cap: US$142.9m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

TerrAscend

Market Cap: US$136.7m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Organigram Global

Market Cap: US$198.0m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

Pharming Group

Market Cap: US$479.4m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.

Shionogi

Market Cap: US$2.0t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.

Regeneron Pharmaceuticals

Market Cap: US$58.8b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

United Therapeutics

Market Cap: US$12.8b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Hypera

Market Cap: US$12.6b

Operates as a pharmaceutical company in Brazil.

Akoya Biosciences

Market Cap: US$54.8m

A life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa.

Xeris Biopharma Holdings

Market Cap: US$628.1m

A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.

Elanco Animal Health

Market Cap: US$4.0b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Inotiv

Market Cap: US$55.9m

Provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally.

MariMed

Market Cap: US$31.8m

Engages in cultivation, production, and selling of branded cannabis products in the United States and internationally.

Genmab

Market Cap: US$81.9b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.